Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

INTERIM MANAGEMENT STATEMENT

15 May 2025 11:44

RNS Number : 8566I
Mandarin Oriental International Ltd
15 May 2025
Β 

ANNOUNCEMENT

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

15 May 2025 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2025.

Β 

Laurent Kleitman, Group Chief Executive, said:

"Clear vision, strategy, and sharpened focus have enabled early wins this year with solid growth in RevPAR and market share globally. We have strategically expanded our global footprint - most notably with the addition of the iconic Mandarin Oriental Lutetia, Paris, to our portfolio. Concurrently, we continue to elevate the brand through significant investments in our founding flagship hotels in Hong Kong and Bangkok, reinforcing our commitment to delivering exceptional, brand-led, guest-centric experiences. We remain focused on driving long-term value creation for the Group as we execute our growth

strategy."

Β 

In Q1, the Group reported higher Revenue per Available Room ('RevPAR') in all regions compared to the prior year. The Management Business drove higher hotel management fee income from strong hotel RevPARs and continued to invest in the capability to enable the Group to execute against its long-term growth strategy. Owned Hotels, particularly in Hong Kong, generated higher profitability than the prior year, offsetting the absence of earnings from Paris following the disposal of that hotel property in 2024. Overall, the Group's underlying profit in the quarter was higher than last year.

Β 

The Group has also made excellent progress in accelerating the growth of its portfolio. In the first quarter, two new hotel and residences management agreements were announced: a resort with residences in Puerto Rico, offering an immersive experience at Esencia in BoquerΓ³n Bay, and a luxury hotel in Suzhou, China, featuring panoramic views of the renowned Jinji Lake. In April, the Group strengthened its European presence with the opening of its second property in Paris - Mandarin Oriental Lutetia, Paris. The Group also took over the management of The Conservatorium Hotel, its first flag in Amsterdam, and targets to complete the rebranding of this property in 2026.

Β 

Reaffirming our commitment to delivering brand-led, guest-centric experiences, in April, the Group announced substantial multi-million-dollar investments into its two founding flagship hotels - Mandarin Oriental, Hong Kong, and Mandarin Oriental, Bangkok. This dedication was also recognised with Amber at The Landmark Mandarin Oriental, Hong Kong, earning three coveted Michelin stars in March - a testament to the Group's relentless pursuit of exceptional culinary experiences.

Β 

One Causeway Bay - the Group's mixed-use commercial redevelopment in Hong Kong remains on budget and on track to be completed in the second half of the year. The Group's liquidity position remains robust, with US$462 million headroom in available committed debt facilities and US$178 million of cash reserves. Gearing was 3% of adjusted shareholders' funds, slightly higher than 2% at the end of last year.

Β 

Mandarin Oriental Hotel Group is the award-winning owner and operator of some of the world's most luxurious hotels, resorts and residences. Having grown from its Asian roots into a global brand, the Group now operates 43 hotels, 12 residences and 26 exceptional homes in 26 countries and territories, with each property reflecting the Group's oriental heritage, local culture and unique design. Mandarin Oriental has a strong pipeline of hotels and residences under development.

Β 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the equity shares (transition) category of the London Stock Exchange, with secondary listings in Bermuda and Singapore. The activities of the Group's hotels are managed from Hong Kong. Mandarin Oriental is a member of the Jardine Matheson group.

Β 

- end -

Β 

For further information, please contact:

Β 

Max Fleming (Director of Corporate Finance) (852) 2895 9171

Β 

Chris Orlikowski (Director of Global Communications) (44) 791 7280 210

William Brocklehurst (Brunswick Group Limited) (852) 5685 9881

Β 

This and other Group announcements can be accessed online at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DOCBELFFEELZBBB
Date   Source Headline
25th Oct 201910:47 amRNSTransaction in Own Shares
22nd Oct 201910:47 amRNSTransaction in Own Shares
21st Oct 201910:40 amRNSTransaction in Own Shares
18th Oct 201910:42 amRNSTransaction in Own Shares
17th Oct 201911:00 amRNSTransaction in Own Shares
17th Oct 201910:44 amRNSDirector/PDMR Shareholding
16th Oct 201911:00 amRNSTransaction in Own Shares
11th Oct 201911:02 amRNSAdditional Listing
8th Oct 201910:54 amRNSTransaction in Own Shares
3rd Oct 201911:19 amRNSTransaction in Own Shares
2nd Oct 201910:23 amRNSDirector Declaration
2nd Oct 201910:22 amRNSDividend
30th Sep 201910:56 amRNSTransaction in Own Shares
30th Sep 201910:54 amRNSTotal Voting Rights
27th Sep 201911:28 amRNSDividend
26th Sep 201911:08 amRNSTransaction in Own Shares
25th Sep 201910:29 amRNSBlock listing Interim Review
23rd Sep 201910:57 amRNSDirector/PDMR Shareholding
19th Sep 201911:38 amRNSTransaction in Own Shares
4th Sep 201910:30 amRNSCirc re. Scrip Dividend Scheme
30th Aug 201910:26 amRNSTotal Voting Rights
28th Aug 201910:19 amRNSDirector/PDMR Shareholding
27th Aug 20197:00 amRNSDirector/PDMR Shareholding
23rd Aug 201910:13 amRNSDirector/PDMR Shareholding
15th Aug 201910:20 amRNSDirector/PDMR Shareholding
7th Aug 201910:22 amRNSDirector/PDMR Shareholding
2nd Aug 201910:53 amRNSHalf-year Report
2nd Aug 201910:45 amRNSHalf-year Report
2nd Aug 201910:40 amRNSHalf-year Report
1st Aug 201910:16 amRNSHalf-year Report
1st Aug 201910:16 amRNSHalf-year Report
1st Aug 201910:16 amRNSHalf-year Report
31st Jul 201910:33 amRNSFirst Half 2019 Results of PT Hero
31st Jul 20197:35 amRNSTotal Voting Rights
30th Jul 201910:49 amRNSPT Astra Intl Tbk - 2019 First Half Fin Statements
4th Jul 201910:19 amRNSNotice of 2019 Half-Yearly Results
2nd Jul 20197:00 amRNSDirector/PDMR Shareholding
28th Jun 201910:34 amRNSExtractive Sector: Payments to Govts Report 2018
21st Jun 201910:33 amRNSDirector/PDMR Shareholding
11th Jun 201910:47 amRNSDirector/PDMR Shareholding
31st May 201910:14 amRNSTotal Voting Rights
24th May 201910:23 amRNSDirector/PDMR Shareholding
15th May 201910:13 amRNSDirector/PDMR Shareholding
10th May 201910:10 amRNSAdditional Listing
9th May 20194:31 pmRNSAGM Statement
9th May 20194:23 pmRNSResult of AGM
9th May 201912:33 pmRNSInterim Management Statement
9th May 201912:32 pmRNSInterim Management Statement
8th May 201912:36 pmRNSInterim Management Statement
8th May 201912:36 pmRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.